A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer.
Nadal E, Saleh M, Aix SP, Ochoa-de-Olza M, Patel SP, Antonia S, Zhao Y, Gueorguieva I, Man M, Estrem ST, Liu J, Avsar E, Lin WH, Benhadji KA, Gandhi L, Guba SC, Diaz IA.
Nadal E, et al. Among authors: antonia s.
BMC Cancer. 2023 Jul 28;23(1):708. doi: 10.1186/s12885-023-11153-1.
BMC Cancer. 2023.
PMID: 37507657
Free PMC article.
Clinical Trial.